BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Milner Therapeutics Institute - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.milner.cam.ac.uk
X-WR-CALDESC:Events for The Milner Therapeutics Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260324T160000
DTEND;TZID=Europe/London:20260324T170000
DTSTAMP:20260407T111048
CREATED:20251001T074327Z
LAST-MODIFIED:20260210T104447Z
UID:24266-1774368000-1774371600@www.milner.cam.ac.uk
SUMMARY:Milner Seminar - March 2026
DESCRIPTION:🗓️ 24 March 2026\n⏰ 4:00-5:00pm\n📍Lecture Theatre\, Jeffrey Cheah Biomedical Centre \nJoin us for the March Milner Seminar. Talks will include time for Q&A and will be followed by optional networking and refreshments.\n\nFocus on immunotherapeutics\nSpeakers:\nTim Halim\, CRUK Cambridge Institute – “Tissue-resident innate and adaptive immune cell interactions in health and disease”\nJon Moore\, Epitopea – “Next-generation cancer vaccines: mining the dark genome for novel shared antigens” \nRegister at: milner.glueup.com/event/milner-seminars-focus-on-immunotherapeutics-169505/ \nFor more information about Milner Seminars\, visit: milner.cam.ac.uk/milner-seminar-series
URL:https://www.milner.cam.ac.uk/event/milner-seminar-march-2026/
LOCATION:Lecture Theatre\, Jeffrey Cheah Biomedical Centre\, Puddicombe Way\, Cambridge\, CB2 0AW
ORGANIZER;CN="Milner Therapeutics Institute":MAILTO:events@milner.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260326T120000
DTEND;TZID=Europe/London:20260326T133000
DTSTAMP:20260407T111048
CREATED:20260306T152659Z
LAST-MODIFIED:20260306T152713Z
UID:26107-1774526400-1774531800@www.milner.cam.ac.uk
SUMMARY:Founders Growth Community Spring Walk
DESCRIPTION:🗓️ 26 March  ⏰ 12:00-1:30pm\nMeet at: The Glasshouse\, 1st Floor\, Botanic House\, Cambridge \n\nJoin Founders Growth Community x Innovate Cambridge for a refreshing networking event in the beautiful Cambridge University Botanic Garden. \nStep away from the lab and laptop\, connect with fellow pre-Series A life science and biotech founders\, and share insights\, challenges and ideas- while enjoying nature’s best accelerator: fresh air and good conversation. Tickets to the Botanic Garden will be complimentary. \n\nSign up here: tickettailor.com/events/foundersgrowthcommunity/2098602
URL:https://www.milner.cam.ac.uk/event/founders-growth-community-spring-walk/
LOCATION:The Glasshouse\, Botanic House\, Cambridge\, Cambridgeshire\, CB2 1PH\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260331T150000
DTEND;TZID=Europe/London:20260331T160000
DTSTAMP:20260407T111048
CREATED:20260216T124023Z
LAST-MODIFIED:20260216T124138Z
UID:26037-1774969200-1774972800@www.milner.cam.ac.uk
SUMMARY:Milner Therapeutics Institute: Driving innovation and therapeutic discoveries across the ecosystem
DESCRIPTION:🗓️ 31 March ⏰ 3:00-4:00pm 📍Lecture Theatre\, Jeffrey Cheah Biomedical Centre \nThis event is presented as part of the 2026 Cambridge Festival​. \nSince its inception in 2016\, the Milner Therapeutics Institute​ has been a driving force in connecting academia and business in Cambridge and beyond. With a distinctive model that unites therapeutics research\, partnerships\, and enterprise\, the Institute aims to transform pioneering science into life-changing therapies.  \nAt this event\, our Executive Director Professor Cathy Tralau-Stewart will reflect on how Professor Sir Tony Kouzarides turned a bold vision into reality – launching a completely new and unique department that bridged the gap between academia and industry. Cathy will explore how this innovative model compares with other translational research institutes around the world\, highlighting what makes Milner distinct in its approach and impact. She will also chart the Institute’s journey to date\, celebrate key milestones\, and share her perspective on how Milner will continue to drive discovery and innovation in the life sciences. \nRegister at: milner.glueup.com/event/milner-therapeutics-institute-driving-innovation-and-therapeutic-discoveries-across-the-ecosystem-160327/
URL:https://www.milner.cam.ac.uk/event/milner-therapeutics-institute-driving-innovation-and-therapeutic-discoveries-across-the-ecosystem/
LOCATION:Lecture Theatre\, Jeffrey Cheah Biomedical Centre\, Puddicombe Way\, Cambridge\, CB2 0AW
ORGANIZER;CN="Milner Therapeutics Institute":MAILTO:events@milner.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260414T080000
DTEND;TZID=Europe/London:20260414T170000
DTSTAMP:20260407T111048
CREATED:20260330T153541Z
LAST-MODIFIED:20260330T153541Z
UID:26253-1776153600-1776186000@www.milner.cam.ac.uk
SUMMARY:BioTrinity 2026
DESCRIPTION:The Milner Therapeutics Institute will be represented at BioTrinity2026 on 14 April! \nMilner Incubator Showcase\n⏰ 3:05-3:50pm\n📍 Interact Room\nWe’ll be showcasing a lineup of our incubator companies and partnerships driving innovation forward. \nUnlocking the Power of Collaboration\n⏰ 3:30-3:0pm\n📍 Main Session\nJoin Milner Executive Director Cathy Tralau-Stewart for this panel session. Collaboration is a key component of an R&D SME’s growth strategy\, and this session aims explores how leaders can unlock the full value of partnerships — across academia\, industry\, investors\, and the NHS — to accelerate development\, share risk and extend capability. Panellists will examine what makes collaborations work in practice and how to structure them for long-term impact. \nRegister at:  obn.glueup.com/event/biotrinity-2026-140616/home.html
URL:https://www.milner.cam.ac.uk/event/biotrinity-2026/
LOCATION:Convene\, 133 Houndsditch\, London\, EC3A 7BX\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260414T110000
DTEND;TZID=Europe/London:20260414T120000
DTSTAMP:20260407T111048
CREATED:20260210T085002Z
LAST-MODIFIED:20260217T085539Z
UID:25952-1776164400-1776168000@www.milner.cam.ac.uk
SUMMARY:FGSL Webinar: Single-cell Intercellular CRISPR Screen Reveals Stromal Regulators of Colorectal Cancer Plasticity
DESCRIPTION:🗓️ 14 April\n⏰ 11:00am-12:00pm\n📍 Online \nJoin the Functional Genomics Screening Laboratory (FGSL) team as we welcome Corinne Molyneux for this special webinar. \nSpeaker: Corinne Molyneux\, University College London\n\nAbstract: Colorectal cancer (CRC) displays high levels of nongenetic phenotypic plasticity\, allowing cancer cells to dynamically shift between different functions\, enabling therapy evasion. This is particularly evident in poor prognosis\, stromal-rich CRC tumours. These tumours also have an elevated presence of revival cancer stem cells (revCSCs). In the microenvironment of these tumours cancer-associated fibroblasts (CAFs) act as dynamic regulators driving the reversible acquisition of YAP-dependant\, slow-cycling\, chemoresistant features that define the revCSC state. The soluble factors that are regulating this transition were however undefined. \nTo resolve this question\, we developed a high-throughput single-cell CRISPR assay to systematically perturb the CAF secretome when in direct co-culture with patient derived organoids (PDO). Individual components of the secretome were targeted by synthetic gRNAs in Cas9 expressing CAFs before co-culture. The perturbed co-cultures were then assessed via multiplexed mass cytometry\, capturing cell fate markers\, post-translational modification (PTM) signalling\, cell-cycle activity\, and apoptosis in both PDOs and CAFs at single-cell resolution. \nUsing this platform we have successfully targeted 202 ligands in our PDO+CAF model and quantified the role of each in the revCSC transition\, unveiling the primary effector of stromal-induced CRC plasticity changes. These findings demonstrate that CRC phenotypic plasticity is regulated by stromal-derived signals\, providing new mechanistic insight into therapy failure and describing a potential therapeutic intervention strategy to overcome plasticity driven chemoresistance. \nRegister at: cam-ac-uk.zoom.us/meeting/register/I4NjVGD2T4Oui4FWDTaJrw#/registration
URL:https://www.milner.cam.ac.uk/event/fgsl-webinar-single-cell-intercellular-crispr-screen-reveals-stromal-regulators-of-colorectal-cancer-plasticity/
LOCATION:Online
ORGANIZER;CN="Milner Therapeutics Institute":MAILTO:events@milner.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260416T120000
DTEND;TZID=Europe/London:20260416T133000
DTSTAMP:20260407T111048
CREATED:20260327T134123Z
LAST-MODIFIED:20260327T142200Z
UID:26219-1776340800-1776346200@www.milner.cam.ac.uk
SUMMARY:Partnering with Curie.Bio: Turning Ideas into Therapies
DESCRIPTION:Turning Ideas into Therapies: an opportunity to connect with a leading therapeutics investor Curie.Bio\n🗓️  16 April   ⏰ 12:00-1:30pm\n📍 Lecture Theatre\, Jeffrey Cheah Biomedical Centre \nJoin the Milner Therapeutics Institute and Cambridge Enterprise for a seminar showcase and networking event with the leadership team at US venture firm Curie.Bio. \nCurie.Bio is a US venture capital firm and accelerator that helps founders discover and develop novel therapeutics. The company was created with the aim of removing the typical bottlenecks and boundaries that get in the way of creating drugs. To achieve this\, the company collaborates closely with founders to reach better milestones in initial funding rounds\, which in turn increase founders’ probabilities of success. \nAt this event\, Christoph Lengauer\, Founder and CSO\, and members of the leadership team will showcase Curie.Bio’s differentiated approach including how they collaborate with founders\, illustrated by a Q&A with Prof Gabriel Balmus\, Group Leader at the UK Dementia Institute and CEO at FunctionRx. The company is working on discovering oral small molecule targeting MSH3 to halt Huntington‘s disease and other repeat expansion disorders at a very early stage. \nRegister at: tickettailor.com/events/milnerinstitute/2132156
URL:https://www.milner.cam.ac.uk/event/partnering-with-curie-bio-turning-ideas-into-therapies/
LOCATION:Lecture Theatre\, Jeffrey Cheah Biomedical Centre\, Puddicombe Way\, Cambridge\, CB2 0AW
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260416T153000
DTEND;TZID=Europe/London:20260416T180000
DTSTAMP:20260407T111048
CREATED:20260327T114723Z
LAST-MODIFIED:20260327T114723Z
UID:26213-1776353400-1776362400@www.milner.cam.ac.uk
SUMMARY:Founders Growth Community Masterclass - Is there a secret to getting 10 drugs approved?
DESCRIPTION:🗓️  16 April\n⏰  3:30-5:30pm\n📍 Deloitte\, One Station Square\, Cambridge CB1 2GA \nJoin The Founders Growth Community for an exclusive masterclass with one of biotech’s most accomplished scientific leaders – Christoph Lengauer\, Chief Scientific Officer at Curie.Bio. \nWhat does it really take to bring a drug from discovery to approval — let alone ten? \nIn this candid and insight-driven session\, Christoph Lengauer will draw on his extraordinary career across biotech\, pharma\, and venture to unpack the realities behind successful drug development. From scientific decision-making to leadership at scale\, this masterclass will explore the patterns\, principles\, and critical inflection points that underpin breakthrough success. \nExpect honest reflections\, practical insights\, and the opportunity to learn from someone who has repeatedly operated at the forefront of innovation. \nRegister at: tickettailor.com/events/foundersgrowthcommunity/2101242 \n 
URL:https://www.milner.cam.ac.uk/event/founders-growth-community-masterclass-is-there-a-secret-to-getting-10-drugs-approved/
LOCATION:Deloitte\, One Station Square\, Cambridge\, CB1 2GA\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260422T160000
DTEND;TZID=Europe/London:20260422T173000
DTSTAMP:20260407T111048
CREATED:20260327T101428Z
LAST-MODIFIED:20260327T101428Z
UID:26209-1776873600-1776879000@www.milner.cam.ac.uk
SUMMARY:BioVentures Investor Showcase 2026
DESCRIPTION:🗓️  22 April  ⏰ 4:00-5:30pm\n📍Online \nCambridge University Health Partners (CUHP) and the Milner Therapeutics Institute\, University of Cambridge are pleased to bring together some of the most exciting biotech and life sciences companies from the Cambridge ecosystem with a curated network of venture capital investors\, for an evening of focused pitching and meaningful connections. \nParticipating companies are Milner Bio-incubator companies and Milner affiliated companies who will pitch to investors in dedicated virtual breakout rooms\, covering areas including oncology\, longevity\, drug discovery\, med tech\, and more. \nRegister at: milner.glueup.com/event/bioventures-investor-showcase-2026-173173/
URL:https://www.milner.cam.ac.uk/event/bioventures-investor-showcase-2026/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260515T163000
DTEND;TZID=Europe/London:20260515T200000
DTSTAMP:20260407T111048
CREATED:20260327T100525Z
LAST-MODIFIED:20260330T095909Z
UID:26207-1778862600-1778875200@www.milner.cam.ac.uk
SUMMARY:Gravity x Milner Therapeutics Institute Biotech Matchmaking Event
DESCRIPTION:🗓️ 15 May\n⏰ 4:30-8:00pm\n📍 Jeffrey Cheah Biomedical Centre\, Cambridge Biomedical Campus\n \nSave the date for a matchmaking event for early career scientists! This event aims to matchmake students and postdocs with biotech firms\, creating connections that may lead to placement opportunities\, collaborations\, and future careers in industry. \nOrganised by Cambridge Gravity in collaboration with the Milner Therapeutics Institute\, the event will bring together biotech companies from the Milner Institute’s affiliated company network\, alongside start-ups based within the Milner Bio-Incubator. \nRegister at: tickettailor.com/events/cambridgegravity/2124196
URL:https://www.milner.cam.ac.uk/event/gravity-x-milner-therapeutics-institute-biotech-matchmaking-event-2/
LOCATION:Lecture Theatre\, Jeffrey Cheah Biomedical Centre\, Puddicombe Way\, Cambridge\, CB2 0AW
ORGANIZER;CN="Cambridge Gravity":MAILTO:contact@gravity.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260519T160000
DTEND;TZID=Europe/London:20260519T170000
DTSTAMP:20260407T111048
CREATED:20251001T074553Z
LAST-MODIFIED:20260402T130350Z
UID:24268-1779206400-1779210000@www.milner.cam.ac.uk
SUMMARY:Milner Seminar - May 2026
DESCRIPTION:🗓️ 19 May 2026\n⏰ 4:00-5:00pm\n📍Lecture Theatre\, Jeffrey Cheah Biomedical Centre \nFocus on RNA Therapeutics\nSpeakers:\nKonstantinos Tzelepis\, Cambridge Stem Cell Institute\, University of Cambridge\nAdi Naamati\, Eleven Therapeutics \nMilner Seminars are designed to facilitate interdisciplinary connections. Seminars include speakers from both academia and industry/biotech\, each addressing a common theme\, and are followed by networking over refreshments.\nRegistration and more details to follow soon.
URL:https://www.milner.cam.ac.uk/event/milner-seminar-may-2026/
LOCATION:Lecture Theatre\, Jeffrey Cheah Biomedical Centre\, Puddicombe Way\, Cambridge\, CB2 0AW
ORGANIZER;CN="Milner Therapeutics Institute":MAILTO:events@milner.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260706T150000
DTEND;TZID=Europe/London:20260706T213000
DTSTAMP:20260407T111048
CREATED:20250711T091838Z
LAST-MODIFIED:20260327T095111Z
UID:23569-1783350000-1783373400@www.milner.cam.ac.uk
SUMMARY:Milner Pitch Day 2026
DESCRIPTION:🗓️ 6th July\n⏰ 3:00-6:00pm (pitches)\, 6:30-9:00pm (networking)\n📍 Jesus College\, Cambridge (pitches). The Lab\, Cambridge (networking) and online \nOur annual showcase highlights promising Pre-Series A companies from our bio-incubator\, local accelerators\, as well as other selected national and international companies. This event is aimed at investors and funders in the life sciences sector. \nSelected Pre-Series A companies will showcase their companies in a 5-minute pitch followed by a 2-minute Q&A with investors. These companies are pushing the boundaries in cutting-edge research areas\, including oncology\, longevity\, neuroscience\, rare disease\, immune therapy\, drug discovery\, and more. Pitches will be followed by networking at the The Lab.  \nFor more information and to register\, visit: milner.glueup.com/event/milner-pitch-day-2026-171284/
URL:https://www.milner.cam.ac.uk/event/milner-pitch-day-2026/
LOCATION:West Court\, Jesus College\, CB5 8BL
ORGANIZER;CN="Milner Therapeutics Institute":MAILTO:events@milner.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260707T120000
DTEND;TZID=Europe/London:20260707T183000
DTSTAMP:20260407T111048
CREATED:20250708T145137Z
LAST-MODIFIED:20260212T104151Z
UID:23474-1783425600-1783449000@www.milner.cam.ac.uk
SUMMARY:Milner Therapeutics Symposium 2026
DESCRIPTION:🗓️ 7 July 2026\n⏰ 12:00pm-6:30pm\n📍 West Road Concert Hall\, Cambridge and online \nThe Milner Therapeutics Symposium takes place annually in Cambridge\, UK\, hosting ~500 delegates in person and >250 online. The Symposium is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma and biotech towards new treatments. It is our key networking event to foster collaborations within the Milner Therapeutics Institute partner organisations. \nClick here to register!
URL:https://www.milner.cam.ac.uk/event/milner-therapeutics-symposium-2026/
LOCATION:West Road Concert Hall and online\, 11 West Road\, Cambridge\, Cambridgeshire\, CB3 9DP\, United Kingdom
ORGANIZER;CN="Milner Therapeutics Institute":MAILTO:events@milner.cam.ac.uk
END:VEVENT
END:VCALENDAR